Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients
Bortezomib induced peripheral neuropathy is a dose-limiting side effect and a major concern in the treatment of multiple myeloma. To identify genetic risk factors associated with the development of this side effect in bortezomib treated multiple myeloma patients, a pharmacogenetic association study...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Haematologica, the hematology journal
Year: 2011, Jahrgang: 96, Heft: 11, Pages: 1728-1732 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2011.041434 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2011.041434 Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/6136 
|
| Verfasserangaben: | Sophie L. Corthals, Rowan Kuiper, David C. Johnson, Pieter Sonneveld, Roman Hajek, Bronno van der Holt, Florence Magrangeas, Hartmut Goldschmidt, Gareth J. Morgan, and Hervé Avet-Loiseau |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1799545466 | ||
| 003 | DE-627 | ||
| 005 | 20230427072613.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220413s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2011.041434 |2 doi | |
| 035 | |a (DE-627)1799545466 | ||
| 035 | |a (DE-599)KXP1799545466 | ||
| 035 | |a (OCoLC)1341458804 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Corthals, Sophie L. |e VerfasserIn |0 (DE-588)1255327626 |0 (DE-627)1799545318 |4 aut | |
| 245 | 1 | 0 | |a Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients |c Sophie L. Corthals, Rowan Kuiper, David C. Johnson, Pieter Sonneveld, Roman Hajek, Bronno van der Holt, Florence Magrangeas, Hartmut Goldschmidt, Gareth J. Morgan, and Hervé Avet-Loiseau |
| 264 | 1 | |c 2011 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.04.2022 | ||
| 520 | |a Bortezomib induced peripheral neuropathy is a dose-limiting side effect and a major concern in the treatment of multiple myeloma. To identify genetic risk factors associated with the development of this side effect in bortezomib treated multiple myeloma patients, a pharmacogenetic association study was performed using a discovery set (IFM 2005-01; n=238) and a validation set (HOVON65/GMMG-HD4 and a Czech dataset; n=231). After multiplicity correction, none of the 2,149 single nucleotide polymorphisms tested revealed any significant association with bortezomib induced peripheral neuropathy. However, 56 single nucleotide polymorphisms demonstrated an association with bortezomib induced peripheral neuropathy with pointwise, uncorrected significance. Pathway analysis of these polymorphisms demonstrated involvement of neurological disease (FDR | ||
| 700 | 1 | |a Kuiper, Rowan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Johnson, David C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sonneveld, Pieter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hajek, Roman |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holt, Bronno van der |e VerfasserIn |4 aut | |
| 700 | 1 | |a Magrangeas, Florence |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Morgan, Gareth J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Avet-Loiseau, Hervé |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica, the hematology journal |d Pavia : Ferrata Storti Foundation, 2005 |g 96(2011), 11 vom: Nov., Seite 1728-1732 |h Online-Ressource |w (DE-627)48524375X |w (DE-600)2186022-1 |w (DE-576)414771095 |x 1592-8721 |7 nnas |a Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients |
| 773 | 1 | 8 | |g volume:96 |g year:2011 |g number:11 |g month:11 |g pages:1728-1732 |g extent:5 |a Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2011.041434 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/6136 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220413 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN1799545466 |e 4117315285 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"family":"Corthals","display":"Corthals, Sophie L.","role":"aut","given":"Sophie L."},{"display":"Kuiper, Rowan","family":"Kuiper","role":"aut","given":"Rowan"},{"family":"Johnson","display":"Johnson, David C.","role":"aut","given":"David C."},{"display":"Sonneveld, Pieter","family":"Sonneveld","given":"Pieter","role":"aut"},{"display":"Hajek, Roman","family":"Hajek","role":"aut","given":"Roman"},{"family":"Holt","display":"Holt, Bronno van der","given":"Bronno van der","role":"aut"},{"family":"Magrangeas","display":"Magrangeas, Florence","given":"Florence","role":"aut"},{"role":"aut","given":"Hartmut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"given":"Gareth J.","role":"aut","family":"Morgan","display":"Morgan, Gareth J."},{"display":"Avet-Loiseau, Hervé","family":"Avet-Loiseau","given":"Hervé","role":"aut"}],"name":{"displayForm":["Sophie L. Corthals, Rowan Kuiper, David C. Johnson, Pieter Sonneveld, Roman Hajek, Bronno van der Holt, Florence Magrangeas, Hartmut Goldschmidt, Gareth J. Morgan, and Hervé Avet-Loiseau"]},"physDesc":[{"extent":"5 S."}],"recId":"1799545466","relHost":[{"part":{"issue":"11","text":"96(2011), 11 vom: Nov., Seite 1728-1732","pages":"1728-1732","year":"2011","extent":"5","volume":"96"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patientsHaematologica, the hematology journal","note":["Gesehen am 27.09.2018"],"origin":[{"dateIssuedDisp":"2005-2013","dateIssuedKey":"2005","publisher":"Ferrata Storti Foundation","publisherPlace":"Pavia"}],"pubHistory":["90.2005 - 98.2013"],"title":[{"title_sort":"Haematologica, the hematology journal","subtitle":"official organ of the European Hematology Association","title":"Haematologica, the hematology journal"}],"id":{"eki":["48524375X"],"zdb":["2186022-1"],"issn":["1592-8721"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"48524375X"}],"id":{"doi":["10.3324/haematol.2011.041434"],"eki":["1799545466"]},"origin":[{"dateIssuedDisp":"2011","dateIssuedKey":"2011"}],"note":["Gesehen am 13.04.2022"],"title":[{"title_sort":"Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients","title":"Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a CORTHALSSOGENETICFAC2011 | ||